XSHE
300253
Market cap2.55bUSD
Dec 05, Last price
8.18CNY
1D
1.49%
1Q
-13.80%
Jan 2017
-20.66%
IPO
78.21%
Name
Winning Health Technology Group Co Ltd
Chart & Performance
P/E
204.92
P/S
6.47
EPS
0.04
Div Yield, %
0.24%
Shrs. gr., 5y
0.43%
Rev. gr., 5y
7.84%
Revenues
2.78b
-12.05%
Net income
88m
-75.45%
CFO
408m
+120.53%
Dividend
Jun 04, 20240.02 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Winning Health Technology Group Co., Ltd. provides IT solutions for hospitals and medical service organizations in China. The company offers IT solution designing, planning and consulting, development, system building, maintenance, and operation services. Its solutions are used in building smart hospitals, regional healthcare regulation platforms, community healthcare regulation platforms, public health-care regulation platforms, medical insurance, and other health services. The company was formerly known as Shanghai Kingstar Winning Software Co., Ltd. and changed its name to Winning Health Technology Group Co., Ltd. in January 2016. Winning Health Technology Group Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||